A US biopharmaceutical company has been selected to receive a grant from the Michael J. Fox Foundation to develop gene therapy for Parkinson s disease (PD) and other rare diseases, according to reports from New York Times and the US state-run Financial Times.
Source: streetinsider.comPublished on 2022-08-24
Related news
- Governor Lamont Marks International Open Data Day 2022
- Portuguese energy distributor E - REDES selects Opendatasoft for new open data portal
- Global Big Data Markets Analysis Report 2023 : Big Data in
- Data Reform Bill announced in Queen Speech
- Artificial intelligence spots pests in trail cams , and tracks indigenous plants from orbit
- Europol gears up to collect big data on European citizens after MEPs vote to expand policing power
- Global Big Data Markets Analysis Report 2023 - 2028 : Most Extensive Coverage of Leading Companies , Solutions , Use Cases , Infrastructure , Data Integration , IoT Support , Deployment Model and Services
- Europol gears up to collect big data on European citizens after MEPs vote to expand policing power -- Puppet Masters -- Sott . net
- What will happen around the world of data in 2022 ?
- Mastercard Is Hiring Young Professionals to Expand Crypto and ESG Consulting
- Travel Insurance Market to be Worth $63 . 9 Billion by 2030 : Grand View Research , Inc .
- Oracle to invest $1 . 5 bln in Saudi Arabia
- Space - based system can provide seismic monitoring for large earthquakes and tsunamis
- Effects of the renewal on the StatFin database and its interfaces
- TomTom co - founds Overture Maps Foundation to build Open Map Data